GEOVAX LABS INC (GOVX)

NASDAQHealth CareBiotechnologySnapshot 2026-09-04

$0.48-4.68%

Close 2026-09-04 · 1-day change

QuarterlyIQ Insights · GOVX

Financials

Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.

Income Statement

Period

View

Order

Figures in millions of USD, except per-share and ratios.

	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011
Revenues
Revenues	—	2.5	4.0	0.0	0.1	0.4	1.8	1.2	1.0	—	—	—	—	—	—	—
Operating Expenses & Income
R&D Expenses	15.1	18.1	23.7	20.7	9.1	15.6	2.4	1.9	1.9	2.0	2.0	1.7	1.8	2.9	3.0	4.3
Operating Income	(20.5)	(21.6)	(25.1)	(26.7)	(14.0)	(18.7)	(2.8)	(2.4)	(2.6)	(2.2)	(3.3)	(2.7)	(2.7)	(2.3)	(2.1)	(2.3)
Earnings from Continuing Operations
Interest Expense	—	—	0.0	—	0.0	0.0	0.1	0.0	0.0	—	—	—	—	—	—	—
Interest & Investment Income	0.1	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net Interest Expenses	—	—	—	—	(0.0)	(0.0)	0.1	(0.0)	(0.0)	—	—	—	—	—	—	—
Other Non-Operating Income / Expenses	—	0.2	0.2	0.8	0.0	0.2	(0.1)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Income Tax Expense	—	—	—	—	—	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Net Income
Net Income	(20.4)	(21.5)	(25.0)	(26.0)	(14.0)	(18.6)	(3.0)	(2.4)	(2.6)	(2.2)	(3.3)	(2.7)	(2.7)	(2.3)	(2.1)	(2.3)
Per Share
Basic EPS	(4.47)	(22.40)	(4.82)	(14.29)	(12.39)	(3.04)	—	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares	4.6	1.0	5.2	1.8	1.1	6.1	—	—	—	—	—	—	—	—	—	15.7
Supplemental
EBITDA	—	(21.6)	(25.1)	(26.7)	(14.0)	(18.7)	(2.8)	(2.4)	(2.5)	(2.1)	(3.2)	(2.7)	(2.7)	(2.2)	(2.0)	(2.2)
EBIT	(20.5)	(21.6)	(25.1)	(26.7)	(14.0)	(18.7)	(2.8)	(2.4)	(2.6)	(2.2)	(3.3)	(2.7)	(2.7)	(2.3)	(2.1)	(2.3)

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.